UNITED LAB(03933),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

03933 UNITED LAB

Market Closed 05-08 16:08:03

9.900

+0.050

+0.51%

High10.250	Low9.760	Vol12.21M
Open9.960	D1 Closing9.850	Amplitude4.97%
Mkt Cap19.53B	Tradable Cap19.53B	Total Shares1.97B
T/O122.04M	T/O Rate0.62%	Tradable Shares1.97B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"03933","market":"HK","secType":"STK","nameCN":"UNITED LAB","latestPrice":9.9,"timestamp":1778227683008,"preClose":9.85,"halted":0,"volume":12213008,"delay":0,"changeRate":0.005076142131979768,"floatShares":1973000000,"shares":1973000000,"eps":1.2744070226413027,"marketStatus":"Market Closed","change":0.05,"latestTime":"05-08 16:08:03","open":9.96,"high":10.25,"low":9.76,"amount":122037136,"amplitude":0.049746,"askPrice":9.91,"askSize":50000,"bidPrice":9.9,"bidSize":130000,"shortable":3,"etf":0,"ttmEps":1.3475428978674413,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1778463000000},"marketStatusCode":7,"adr":0,"listingDate":1181836800000,"exchange":"SEHK","adjPreClose":9.85,"dividendRate":0.04798,"openAndCloseTimeList":[[1778203800000,1778212800000],[1778216400000,1778227200000]],"volumeRatio":2.745989257365754,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03933","defaultTab":"news","newsList":[{"id":"1120779705","title":"Federal Pharmaceutical Rises Over 3% in Intraday Trading as Weekly Long-Acting Insulin Candidate UBT38006 Injection Receives Clinical Trial Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1120779705","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120779705?lang=en_us&edition=fundamental","pubTime":"2026-05-08 10:40","pubTimestamp":1778208031,"startTime":"0","endTime":"0","summary":"Federal Pharmaceutical (03933) saw its shares rise more than 3% during intraday trading. At the time of writing, the stock was up 2.44%, trading at HK$10.09, with a turnover of HK$39.2058 million. On...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03933","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633114722","title":"United Laboratories Unit Gets China Nod for Insulin Product Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2633114722","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633114722?lang=en_us&edition=fundamental","pubTime":"2026-05-07 20:53","pubTimestamp":1778158388,"startTime":"0","endTime":"0","summary":"The United Laboratories International  said Thursday a subsidiary's clinical trial application for its long-acting weekly insulin product secured approval in China.Specifically, China's National Medical Products Administration cleared the testing for United Bio-Technology 's UBT38006 injection.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1191","BK4211","03933","UBCP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100932510","title":"AI Frenzy Shifts from Hardware to Applications, Musk-Related Concepts Gain Traction","url":"https://stock-news.laohu8.com/highlight/detail?id=1100932510","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100932510?lang=en_us&edition=fundamental","pubTime":"2026-05-07 20:13","pubTimestamp":1778155986,"startTime":"0","endTime":"0","summary":"The U.S. stock market saw the S&P 500 and Nasdaq indices hit new highs overnight due to continuous positive signals, which naturally influenced domestic markets. Hong Kong stocks opened higher today,...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGIX","BK1589","VXUS","01177","BK4585","SG9999015945.SGD","BK1593","BK1521","BK1583","BK1191","IE00BYV24P56.USD","LU2097828557.USD","BK1515","LU2097828631.EUR","BK1161","IE00BZ08YS42.EUR","LU2097828474.EUR","00867","03692","IE00BGHQDM52.EUR","SG9999015952.SGD","SG9999015978.USD","BK4588","LU0502904849.HKD","UFO","IE00BVYPNQ40.USD","LU2328871848.SGD","LU2097828805.USD","SG9999004220.SGD","LU1969619763.USD","IE00BZ08YR35.GBP","HK0000165453.HKD","IE00BVYPNP33.GBP","03933","IE00BMCWC346.EUR","CHAT","LU2242644610.SGD","AIPO","ARTY","LU0455707207.USD","01801","LU2488822045.USD","DXYZ","IE00BZ08YT58.USD","LU2097828714.EUR","SG9999015986.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633117258","title":"BRIEF-United Laboratories International Says China's NMPA Approves Clinical Trial Application For UBT38006 Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2633117258","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633117258?lang=en_us&edition=fundamental","pubTime":"2026-05-07 18:16","pubTimestamp":1778148981,"startTime":"0","endTime":"0","summary":"BRIEF-United Laboratories International Says China's NMPA Approves Clinical Trial Application For UBT38006 InjectionMay 7  - United Laboratories International Holdings Ltd 3933.HK:CHINA NMPA APPROVES CLINICAL TRIAL APPLICATION FOR UBT38006 INJECTIONFurther company coverage: 3933.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nFWN41K0HP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","03933"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118522658","title":"UNITED LAB's UBT38006 Injection Receives Implied Clinical Trial Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1118522658","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118522658?lang=en_us&edition=fundamental","pubTime":"2026-05-07 17:44","pubTimestamp":1778147089,"startTime":"0","endTime":"0","summary":"UNITED LAB (03933) announced that its wholly-owned subsidiary, Federal Biotech (Zhuhai Hengqin) Co., Ltd., has obtained implied clinical trial approval from the National Medical Products...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03933","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633114897","title":"United Labs says China regulator clears UBT38006 weekly insulin for clinical trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2633114897","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633114897?lang=en_us&edition=fundamental","pubTime":"2026-05-07 17:39","pubTimestamp":1778146767,"startTime":"0","endTime":"0","summary":"TUL received China NMPA clearance to start clinical trials of UBT38006 Injection, its self-developed Class 1 innovative drug, under filing number CXSL2600257.UBT38006 is a long-acting insulin candidate designed for once-weekly dosing, targeting improved adherence versus existing insulin regimens.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TUL - The United Laboratories International Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on May 07, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nNDLbzlDGF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03933","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633114856","title":"United Laboratories International - China National Medical Products Administration Approves Clinical Trial Application for Ubt38006 Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2633114856","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633114856?lang=en_us&edition=fundamental","pubTime":"2026-05-07 17:39","pubTimestamp":1778146751,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nFWN41K0CL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["03933","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633088165","title":"Assessing United Laboratories International Holdings (SEHK:3933) Valuation After Dupilumab Biosimilar Trial Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2633088165","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633088165?lang=en_us&edition=fundamental","pubTime":"2026-05-07 05:48","pubTimestamp":1778104137,"startTime":"0","endTime":"0","summary":"Clinical trial approval and what it means for investors\nUnited Laboratories International Holdings (SEHK:3933) has drawn fresh attention after regulators in China approved the clinical trial application for its dupilumab biosimilar targeting atopic dermatitis, a step that highlights progress in its autoimmune pipeline.\nSee our latest analysis for United Laboratories International Holdings.\nThe share price has recently picked up, with a 1-day share price return of 2.77% taking the stock to...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3933/united-laboratories-international-holdings-shares/news/assessing-united-laboratories-international-holdings-sehk393-2","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3933/united-laboratories-international-holdings-shares/news/assessing-united-laboratories-international-holdings-sehk393-2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["03933","UBCP","DCF","BK4211","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185927531","title":"联邦制药聚焦创新与全球拓展，2025年收入132.106亿元同比下降4%，净利润20.859亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1185927531","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185927531?lang=en_us&edition=fundamental","pubTime":"2026-04-29 13:08","pubTimestamp":1777439301,"startTime":"0","endTime":"0","summary":"据联邦制药最新公布的2025年度业绩报告显示，截至2025年12月31日，集团实现全年收入约人民币132.106亿元，同比下降4.0%；归属于公司权益持有人之利润为约人民币20.859亿元，同比减少21.6%。每股盈利为人民币1.1065元。董事会建议派末期股息每股人民币0.26元，加上已派发的中期股息人民币0.16元，全年股息共计每股人民币0.42元，派息率为38.0%。...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"联邦制药聚焦创新与全球拓展，2025年收入132.106亿元同比下降4%，净利润20.859亿元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03933"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631355013","title":"TUL announces annual general meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2631355013","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631355013?lang=en_us&edition=fundamental","pubTime":"2026-04-29 13:00","pubTimestamp":1777438814,"startTime":"0","endTime":"0","summary":"TUL will hold its annual general meeting in Hong Kong on June 23, 2026.Shareholders will vote on adoption of audited consolidated financial statements for year ended Dec. 31, 2025.Resolutions include re-election of directors, plus authorization for board to set directors’ remuneration.Other votes cover re-appointment of Deloitte Touche Tohmatsu as auditor, plus mandates to issue securities, repurchase shares, and extend issuance mandate.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TUL - The United Laboratories International Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 29, 2026, and is solely responsible for t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL4c3msl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03933","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631003557","title":"TUL publishes 2025 annual report","url":"https://stock-news.laohu8.com/highlight/detail?id=2631003557","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631003557?lang=en_us&edition=fundamental","pubTime":"2026-04-29 12:46","pubTimestamp":1777437998,"startTime":"0","endTime":"0","summary":"TUL published its 2025 annual report, highlighting a shift toward finished products growth supported by a major out-licensing deal.Group signed an exclusive global licensing agreement with Novo Nordisk for UBT251 outside Greater China, securing an upfront payment of USD 180 million with potential milestone payments of up to USD 1.8 billion.Pipeline advanced with UBT251 moving into Phase II studies in China across multiple metabolic and renal indications, while UBT37034 entered early-stage clinical development in China and US for overweight or obesity.Capital plan included a new-share placing completed on July 25, 2025, raising net proceeds of HKD 2.17 billion to fund manufacturing expansion and R&D.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or leg","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL9FRwbM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0163747925.USD","LU0259732245.USD","BK1588","LU0029875118.USD","LU1770034418.SGD","LU0359201885.HKD","LU1282651121.HKD","BK1589","LU0164880469.USD","LU0315178854.USD","BK1142","LU0456842615.SGD","LU0293314216.USD","LU0320764755.SGD","LU1720050803.USD","LU0140636845.USD","SGXZ86797644.SGD","LU0469268626.HKD","LU0128522157.USD","LU0051755006.USD","LU1044874839.SGD","LU0048580855.USD","LU0228367735.SGD","LU0348805143.USD","LU0456827905.SGD","LU1808992512.USD","LU0417516902.SGD","LU0431992006.USD","LU1044876610.USD","LU0417516738.SGD","LU0359202008.SGD","89618","LU1224444064.USD","SG9999002828.SGD","BK1619","LU0345775950.USD","LU2257852520.SGD","SGXZ62798434.SGD","LU1303224171.USD","LU1282651048.USD","03933","BK1610","LU0572944931.SGD","LU0211977185.USD","BK1191","LU0865486749.SGD","SG9999002562.SGD","LU0228659784.USD","LU0314109678.HKD","LU1251922891.USD","LU1023057109.AUD","LU0488056044.USD","LU1642822792.SGD","SG9999001226.SGD","LU0348825331.USD","LU0588546209.SGD","IE00BGV7N243.SGD","LU0588545904.SGD","BK1515","LU2039709279.SGD","LU0588545490.SGD","BK1583","LU0828237510.HKD","BK1571","LU1719994722.HKD","LU0320764599.SGD","LU1366334651.USD","BK1591","LU0039217434.USD","LU0531971595.HKD","IE00B3M56506.USD","LU0543330483.HKD","LU1282649810.SGD","LU0315179316.USD","LU0052750758.USD","86618","LU0791590937.USD","LU1366334578.USD","BK1247","LU0384037296.USD","LU0359201612.USD","LU0348735423.USD","LU1282649067.USD","JD","LU0868486357.SGD","LU1481107354.HKD","LU0871576103.HKD","LU1794554557.SGD","LU0084288322.USD","LU0370786039.SGD","IE0032431581.USD","LU0499858438.USD","LU0588545730.USD","LU0345776255.USD","LU0672654166.SGD","LU0708995583.HKD","LU0327786744.USD","BK1615","LU0650527681.SGD","LU1770036033.HKD","LU0456846285.SGD","LU1813983027.USD","LU1044875133.USD","IE00B29SXG58.USD","LU0307460666.USD","LU2242644610.SGD","LU0594300419.USD","LU0164865239.USD","LU0231483743.USD","BK1249","LU0149721374.USD","LU0499858602.USD","LU0791591158.USD","LU1328277881.USD","BK1575","BK1502"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630833303","title":"United Laboratories Unit Gets US FDA Nod for TUL321 Capsules","url":"https://stock-news.laohu8.com/highlight/detail?id=2630833303","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630833303?lang=en_us&edition=fundamental","pubTime":"2026-04-28 18:56","pubTimestamp":1777373769,"startTime":"0","endTime":"0","summary":"The United Laboratories International  unit Zhuhai United Laboratories obtained approval for the new drug application of its TUL321 Capsules from the US Food and Drug Administration , according to a Tuesday Hong Kong bourse filing.The FDA also accepted an application for the clinical trial registration of the drug.The drug is intended to be used in the treatment of paroxysmal nocturnal hemoglobinuria , IgA nephropathy, age-related macular degeneration, multiple sclerosis, and myasthenia gravis.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4211","03933","BK4588","UBCP","BK4585","LABU","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180778081","title":"United Laboratories Secures FDA IND Approval for TUL321 Capsule, a Next-Generation Complement Factor B Inhibitor","url":"https://stock-news.laohu8.com/highlight/detail?id=1180778081","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180778081?lang=en_us&edition=fundamental","pubTime":"2026-04-28 18:04","pubTimestamp":1777370676,"startTime":"0","endTime":"0","summary":"Hong Kong – 28 April 2026 – United Laboratories International Holdings Limited announced that the U.S. Food and Drug Administration has cleared Investigational New Drug application No. 180385 for...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03933"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132660270","title":"UNITED LAB's Novel Drug TUL321 Capsule Receives FDA Clearance for Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=1132660270","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132660270?lang=en_us&edition=fundamental","pubTime":"2026-04-28 17:58","pubTimestamp":1777370307,"startTime":"0","endTime":"0","summary":"UNITED LAB (03933) announced that the Investigational New Drug (IND) application for its Class 1 innovative drug TUL321 Capsule, developed by its wholly-owned subsidiary Zhuhai United Laboratories...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK4588","BK4585","LABU","03933"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630372878","title":"BRIEF-United Laboratories International Says FDA Approves IND Application For TUl321 Capsules","url":"https://stock-news.laohu8.com/highlight/detail?id=2630372878","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630372878?lang=en_us&edition=fundamental","pubTime":"2026-04-28 17:54","pubTimestamp":1777370078,"startTime":"0","endTime":"0","summary":"BRIEF-United Laboratories International Says FDA Approves IND Application For TUl321 Capsules April 28  - United Laboratories International Holdings Ltd 3933.HK:FDA APPROVES IND APPLICATION FOR TUL321 CAPSULES BY UNITED LABFurther company coverage: 3933.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nFWN41B0GZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","03933"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630740053","title":"United Laboratories International - FDA Approves Ind Application for Tul321 Capsules by United Lab","url":"https://stock-news.laohu8.com/highlight/detail?id=2630740053","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630740053?lang=en_us&edition=fundamental","pubTime":"2026-04-28 17:53","pubTimestamp":1777370018,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nFWN41B0GZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","03933"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629086049","title":"United Laboratories' Unit Gets China Nod for Atopic Dermatitis Drug Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2629086049","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629086049?lang=en_us&edition=fundamental","pubTime":"2026-04-22 20:44","pubTimestamp":1776861861,"startTime":"0","endTime":"0","summary":"The United Laboratories International  unit Zhuhai United Bio-Pharmaceutical obtained approval for a clinical trial of dupilumab bio-similar from China's National Medical Products Administration, according to a Wednesday Hong Kong bourse filing.The approved indication is for atopic dermatitis.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4211","UBCP","BK1191","03933"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110058142","title":"UNITED LAB's Dupilumab Biosimilar Receives Clinical Trial Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1110058142","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110058142?lang=en_us&edition=fundamental","pubTime":"2026-04-22 19:23","pubTimestamp":1776857018,"startTime":"0","endTime":"0","summary":"UNITED LAB (03933) announced that its wholly-owned subsidiary, Zhuhai United Laboratories Biopharmaceuticals Co., Ltd., has obtained implied approval from the National Medical Products Administration...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","03933"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629048183","title":"United Labs says China regulator clears dupilumab biosimilar trial for atopic dermatitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2629048183","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629048183?lang=en_us&edition=fundamental","pubTime":"2026-04-22 19:14","pubTimestamp":1776856467,"startTime":"0","endTime":"0","summary":"TUL secured China NMPA clearance to start a clinical trial for its dupilumab biosimilar injection in atopic dermatitis.Zhuhai United Bio-Pharmaceutical, a wholly owned unit, developed product under NMPA filing CXSL2600180.Regulatory go-ahead advances TUL pipeline in inflammatory and autoimmune diseases.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TUL - The United Laboratories International Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 22, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nNDL8d55mN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","03933"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629048908","title":"United Laboratories International - China Nmpa Approves Clinical Trial Application for Dupilumab Bio-Similar for Atopic Dermatitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2629048908","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629048908?lang=en_us&edition=fundamental","pubTime":"2026-04-22 19:14","pubTimestamp":1776856446,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nFWN4150AL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","03933"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tul.com.cn","stockEarnings":[{"period":"1week","weight":0.0554},{"period":"1month","weight":-0.0535},{"period":"3month","weight":-0.2431},{"period":"6month","weight":-0.2124},{"period":"1year","weight":-0.2173},{"period":"ytd","weight":-0.1458}],"compareEarnings":[{"period":"1week","weight":0.0239},{"period":"1month","weight":0.0193},{"period":"3month","weight":-0.0063},{"period":"6month","weight":0.0058},{"period":"1year","weight":0.1588},{"period":"ytd","weight":0.0298}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"The United Laboratories International Holdings Limited is an investment holding company principally engaged in the sales of intermediate products, bulk medicine and finished products. The Company operates its business through three segments. The Intermediate Products segment is engaged in the sale of intermediate products. The Bulk Medicine segment is engaged in the sale of bulk medicine. The Finished Products segment is engaged in the sale of antibiotics finished products, non-antibiotics finished products and capsule casings. Through its subsidiaries, the Company is also engaged in the production and sale of organic fertilizer.","yearOnYearQuotes":[{"month":1,"riseRate":0.368421,"avgChangeRate":-0.033088},{"month":2,"riseRate":0.736842,"avgChangeRate":0.076003},{"month":3,"riseRate":0.631579,"avgChangeRate":0.024575},{"month":4,"riseRate":0.578947,"avgChangeRate":0.07559},{"month":5,"riseRate":0.684211,"avgChangeRate":0.041461},{"month":6,"riseRate":0.277778,"avgChangeRate":-0.012388},{"month":7,"riseRate":0.526316,"avgChangeRate":0.011895},{"month":8,"riseRate":0.473684,"avgChangeRate":0.025474},{"month":9,"riseRate":0.421053,"avgChangeRate":-0.006971},{"month":10,"riseRate":0.631579,"avgChangeRate":-0.000903},{"month":11,"riseRate":0.473684,"avgChangeRate":-0.023163},{"month":12,"riseRate":0.421053,"avgChangeRate":0.011153}],"exchange":"SEHK","name":"UNITED LAB","nameEN":"UNITED LAB"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"UNITED LAB(03933),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest UNITED LAB(03933) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"UNITED LAB,03933,UNITED LAB股票,UNITED LAB股票老虎,UNITED LAB股票老虎国际,UNITED LAB行情,UNITED LAB股票行情,UNITED LAB股价,UNITED LAB股市,UNITED LAB股票价格,UNITED LAB股票交易,UNITED LAB股票购买,UNITED LAB股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"UNITED LAB(03933),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest UNITED LAB(03933) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}